FDA keeps GSK diabetes drug on market but restricts its use

In Europe, regulators stop Avandia sales entirely. “These new restrictions are in response to data that suggest an elevated risk of cardiovascular events, such as heart attack and stroke, in patients treated with Avandia,” the FDA says....